As we recently announced, TMC has a new owner. Unilabs Pathologie SA, Geneva, Switzerland, purchased all TMC’s shares at the end of last year, giving us an even bigger opportunity to continue delivering against TMC’s core purpose: to bring quality healthcare to all people.
We can now do this on an even larger scale and together we will create the first truly integrated digital diagnostic company combining radiology, pathology and, in the future, genomic solutions. In the shorter term, the fact that we will have more doctors in our teams means that we can start to offer more flexible solutions, including increased access to day time emergency reporting services. Everyone will win from this new relationship. Our clients will get better services, our patients will get better outcomes and our colleagues will continue to operate within a company culture where talented people want to come to build their careers.
Unilabs is one of Europe’s largest diagnostic service providers, active in Sweden, Switzerland, the Czech Republic, Denmark, Finland, France, Italy, Norway, Portugal, Slovakia, Spain and the United Kingdom. It also runs laboratories in Dubai and Peru and while its main activity is laboratory testing, it has a strong and growing reputation in radiology, histopathology, drug development and clinical trials. It has recently added genomics to its portfolio
So why this deal between our two businesses?
Unilabs recognised that TMC has an outstanding quality assurance system, a high degree of sub-specialization and a strong reputation. Its leadership was particularly impressed by TMC’s achievements in these areas and wanted to use our skills and experience to transform these capabilities within the wider Unilabs organisation.
In the mid-to-long term, we believe that by being part of a larger organisation we can create a leading integrated diagnostic company with strong, interconnected services in radiology, pathology, labs and genomics, including advanced computer-aided diagnostics and artificial intelligence applications. This means we should be able to provide an even better service to our clients and patients.
On behalf of everybody at TMC, I’d like to thank you for your loyalty and support over the years. We remain committed to delivering unrivalled quality and we are grateful for all the positive reactions we have had from all our stakeholders to this news. We are looking forward to working with you, alongside our Unilab colleagues, as we build an exciting future for us all.
Alexander Boehmcker, CEO